NEW YORK, NY–(Marketwired – Jan 28, 2015) – Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased Medbox, Inc. (“Medbox” or the “Company”) (OTCBB:MDBX) securities between November 20, 2013 and December 29, 2014.

To get more information, click here:https://zlk.9nl.com/medbox-mdbx. There is no cost or obligation to you.

The complaint alleges that during the Class Period defendants concealed that: (a) Medbox was recognizing revenue before earned on certain customer contracts; (b) the Company lacked effective internal controls; (c) due to its false financial reporting, Medbox was not complying with Generally Accepted Accounting Principles or SEC rules and regulations, and thus was not eligible for listing on the national exchange; (d) due to its financial misstatements, Medbox was not in compliance with its debt covenants; and (e) as a result of the aforementioned, Medbox was not on track to achieve its financial targets during the Class Period.

If you suffered a loss in Medbox you have until March 23, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email atjlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visithttps://zlk.9nl.com/medbox-mdbx.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.